1Itokazu GS, Quinn JP, Bell-Dixon C, et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive-care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis, 1996, 23: 779-784.
3Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Psedomonas aeruginosa bacteriemia: outcome correlations in a prospective study of 200 patients. Am J Med, 1989, 87:540-546.
4Lanson EL. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control, 1981, 9: 112-119.
5Urban C, Go E, Mariano N, et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis, 1993, 167: 448-451.
6Ang SW, Lee ST. Emergence of a multiple-resistant strain of Acinetobacter in a bums unit. Ann Acad Med Singapore, 1992, 21:660-603.
7Murray PR, Baron E J, Pfaller MA, et al. Manual of clinical laboratory.7th Edition. Washington DC: American Society for Microbiology, 1999,552-554.
8Quinn JP. Clinical problem posed by multiresistant nonfermenting gramnegative pathogens. Clin Infect Dis, 1998, 27(Suppl 1 ): S117-124.
9Vahaboglu H, Ozturk R, Aygun G, et al. Widespread Detection of PRT-1-Type Extended-Spectrum β-Lactamases among Nosocomiall Acinetobacter and Pseudomonas aeruginosa Osolates in Turkey[J]. Antimicrob Agents Chemother, 1997,41:2265-2269.
10Nordmann P, Naas T. Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases[J].Antimicrob Agents Chemother, 1994,38:104-114.
